ArticleJTO clinical and research reports2022

Successful Tepotinib Challenge After Capmatinib-Induced Interstitial Lung Disease in a Patient With Lung Adenocarcinoma Harboring

Mizuha Haraguchi Hashiguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.